Quinazoline, 4-[(4-bromophenyl)methoxy]- manufacturers
- VEGFR2-IN-2
-
- $32.00 / 1mg
-
2024-10-31
- CAS:737818-56-3
- Min. Order:
- Purity: 99.61%
- Supply Ability: 10g
|
| Quinazoline, 4-[(4-bromophenyl)methoxy]- Basic information |
Product Name: | Quinazoline, 4-[(4-bromophenyl)methoxy]- | Synonyms: | Quinazoline, 4-[(4-bromophenyl)methoxy]-;WAY-340935;4-((4-Bromobenzyl)oxy)quinazoline;WAY-340935(VEGFR2-IN-2);Inhibitor,WAY340935,Vascular endothelial growth factor receptor,WAY 340935,inhibit,VEGFR,Anticancer;VEGFR2-IN-2 | CAS: | 737818-56-3 | MF: | C15H11BrN2O | MW: | 315.16 | EINECS: | | Product Categories: | | Mol File: | 737818-56-3.mol | |
| Quinazoline, 4-[(4-bromophenyl)methoxy]- Chemical Properties |
Boiling point | 455.0±25.0 °C(Predicted) | density | 1.494±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO: 63 mg/mL (199.90 mM);Ethanol: 3 mg/mL (9.52 mM) | pka | 2.66±0.30(Predicted) | form | Solid | color | White to off-white | Water Solubility | Water: Insoluble |
| Quinazoline, 4-[(4-bromophenyl)methoxy]- Usage And Synthesis |
Biological Activity | WAY-340935 (VEGFR2-IN-2) can inhibit the function of VEGFR2 and the anti-proliferative activity against the H460 cell line is produced partly by interaction of VEGFR protein. | References | [1] Sun J, et al. Org Biomol Chem. 2013 Nov 28;11(44):7676-86. |
| Quinazoline, 4-[(4-bromophenyl)methoxy]- Preparation Products And Raw materials |
|